Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 2-((4-(((4-chlorophenyl)(phenyl)carbamoyl)oxy)methyl)cyclohexyl)methoxy)acetate
1. 1187856-49-0
2. Apd-811
3. Apd811
4. Cqy12zjn6e
5. Chembl3919269
6. 2-((trans-4-((((4-chlorophenyl)(phenyl)carbamoyl)oxy)methyl)cyclohexyl)methoxy)acetic Acid
7. 2-[[4-[[(4-chlorophenyl)-phenylcarbamoyl]oxymethyl]cyclohexyl]methoxy]acetic Acid
8. Acetic Acid, 2-((trans-4-(((((4-chlorophenyl)phenylamino)carbonyl)oxy)methyl)cyclohexyl)methoxy)-
9. Ralinepag [usan:inn]
10. Unii-cqy12zjn6e
11. Ralinepag [usan]
12. Ralinepag [inn]
13. Ralinepag (usan/inn)
14. Ralinepag [who-dd]
15. Schembl1118504
16. Schembl1118506
17. Chembl3301604
18. Schembl12786473
19. Schembl21232597
20. Apd 811
21. Bcp30843
22. Bdbm50235385
23. Bdbm50235386
24. Db12462
25. Sb16964
26. Hy-16751
27. Apd-811; Apd 811; Apd811
28. Cs-0012350
29. J3.614.088g
30. D10725
31. P14968
32. An-584/43522715
33. Q27275655
34. ({4-[({[4-chloro(phenyl)anilino]carbonyl}oxy)methyl]cyclohexyl}methoxy)acetic Acid
35. 2-(((1r,4r)-4-((phenyl(p-tolyl)carbamoyloxy)methyl)cyclohexyl)methoxy) Acetic Acid
36. 2-(((1r,4r)-4-((((4-chlorophenyl)(phenyl)carbamoyl)oxy)methyl)cyclohexyl)methoxy)acetic Acid
| Molecular Weight | 431.9 g/mol |
|---|---|
| Molecular Formula | C23H26ClNO5 |
| XLogP3 | 5 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 9 |
| Exact Mass | 431.1499506 g/mol |
| Monoisotopic Mass | 431.1499506 g/mol |
| Topological Polar Surface Area | 76.1 Ų |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 538 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Treatment of pulmonary arterial hypertension
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
75
PharmaCompass offers a list of Ralinepag API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ralinepag manufacturer or Ralinepag supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ralinepag manufacturer or Ralinepag supplier.
PharmaCompass also assists you with knowing the Ralinepag API Price utilized in the formulation of products. Ralinepag API Price is not always fixed or binding as the Ralinepag Price is obtained through a variety of data sources. The Ralinepag Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ralinepag manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ralinepag, including repackagers and relabelers. The FDA regulates Ralinepag manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ralinepag API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Ralinepag supplier is an individual or a company that provides Ralinepag active pharmaceutical ingredient (API) or Ralinepag finished formulations upon request. The Ralinepag suppliers may include Ralinepag API manufacturers, exporters, distributors and traders.
Ralinepag Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ralinepag GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ralinepag GMP manufacturer or Ralinepag GMP API supplier for your needs.
A Ralinepag CoA (Certificate of Analysis) is a formal document that attests to Ralinepag's compliance with Ralinepag specifications and serves as a tool for batch-level quality control.
Ralinepag CoA mostly includes findings from lab analyses of a specific batch. For each Ralinepag CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ralinepag may be tested according to a variety of international standards, such as European Pharmacopoeia (Ralinepag EP), Ralinepag JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ralinepag USP).
